L Patrick Gage insider trades: Cytokinetics (CYTK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where L reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 8, 2021 | CYTK | ↓ Sell | 26,468 | $41.33 | $1.1M | Direct | Nov 8, 2021 (0d) |
| Mar 19, 2021 | CYTK | ↓ Sell | 10,000 | $24.45 | $244K | Direct | Mar 19, 2021 (0d) |
| Mar 12, 2021 | CYTK | ↓ Sell | 10,339 | $21.22 | $219K | Direct | Mar 12, 2021 (0d) |
| Dec 15, 2020 | CYTK | ↓ Sell | 7,716 | $21.00 | $162K | Direct | Dec 15, 2020 (0d) |
| Mar 6, 2020 | CYTK | ↓ Sell | 8,000 | $14.82 | $119K | Direct | Mar 20, 2020 (14d) |
| Nov 29, 2017 | TTPH | ↑ Buy | 3,880 | $6.45 | $25K | Direct | Dec 4, 2017 (5d) |
| Oct 2, 2017 | CYTK | ↓ Sell | 5,000 | $14.59 | $73K | Direct | Oct 4, 2017 (2d) |
| Sep 1, 2017 | CYTK | ↓ Sell | 5,000 | $14.72 | $74K | Direct | Sep 1, 2017 (0d) |
| Aug 29, 2017 | CYTK | ↓ Sell | 5,000 | $14.00 | $70K | Direct | Aug 30, 2017 (1d) |
| Mar 15, 2017 | TTPH | ↑ Buy | 10,000 | $7.49 | $75K | Direct | Mar 16, 2017 (1d) |
| Mar 15, 2017 | TTPH | ↑ Buy | 1,000 | $7.47 | $7K | By Spouse | Mar 16, 2017 (1d) |
| Aug 31, 2015 | CYTK | ↑ Buy | 1,000 | $6.95 | $7K | by Spouse | Sep 1, 2015 (1d) |
| Aug 20, 2015 | CYTK | ↑ Buy | 10,000 | $6.55 | $65K | Direct | Aug 21, 2015 (1d) |
| Aug 12, 2015 | TTPH | ↓ Sell | 15,000 | $45.00 | $675K | Direct | Aug 14, 2015 (2d) |
| May 6, 2015 | CYTK | ↑ Buy | 10,000 | $5.71 | $57K | Direct | May 8, 2015 (2d) |
| Jun 13, 2014 | TTPH | ↑ Buy | 500 | $11.42 | $6K | By wife | Jun 17, 2014 (4d) |
| Jun 5, 2014 | TTPH | ↑ Buy | 975 | $10.28 | $10K | By wife | Jun 9, 2014 (4d) |
| Jun 4, 2014 | TTPH | ↑ Buy | 500 | $10.05 | $5K | By wife | Jun 5, 2014 (1d) |
| May 28, 2014 | TTPH | ↑ Buy | 850 | $10.70 | $9K | By wife | Jun 3, 2014 (6d) |
| May 14, 2014 | TTPH | ↑ Buy | 5,000 | $9.25 | $46K | Direct | May 16, 2014 (2d) |
| May 9, 2014 | CYTK | ↑ Buy | 10,000 | $4.09 | $41K | Direct | May 12, 2014 (3d) |
| May 9, 2014 | CYTK | ↑ Buy | 850 | $4.10 | $3K | by Spouse | May 12, 2014 (3d) |
| Jun 11, 2007 | NTEC | ↑ Buy | 39,500 | $2.60 | $103K | Direct | Jun 12, 2007 (1d) |
| Mar 26, 2007 | NTEC | ↑ Buy | 15,000 | $2.02 | $30K | Direct | Mar 27, 2007 (1d) |
| May 5, 2005 | PDLI | ↑ Buy | 5,555 | $18.05 | $100K | Direct | May 6, 2005 (1d) |
| May 5, 2005 | NTEC | ↑ Buy | 9,200 | $2.78 | $26K | Direct | May 6, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CYTK insiders
Open-market trades in the last 12 months
About L Patrick Gage's insider trades
L Patrick Gage is a director at Cytokinetics (CYTK). Since May 5, 2005, L has reported 17 open-market purchases worth $616K and 9 sales worth $2.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (39 filings), option exercises (12 filings), other transactions (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.